Kelly Elise Dooley

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

Filter
Editorial
2019

Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

Sekaggya-Wiltshire, C. & Dooley, K. E., Aug 3 2019, In : Expert Opinion on Drug Metabolism and Toxicology. 15, 8, p. 615-618 4 p.

Research output: Contribution to journalEditorial

Open Access
Rifamycins
Pharmacodynamics
Pharmacokinetics
Tuberculosis
Anti-Bacterial Agents
2018

High-dose rifampin: Shall we be bolder?

Dooley, K. E., Sep 1 2018, In : American Journal of Respiratory and Critical Care Medicine. 198, 5, p. 558-560 3 p.

Research output: Contribution to journalEditorial

Rifampin
Tuberculosis
Injections
Therapeutics